These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31632439)

  • 1. A Novel Prognostic Signature of Transcription Factors for the Prediction in Patients With GBM.
    Cheng Q; Huang C; Cao H; Lin J; Gong X; Li J; Chen Y; Tian Z; Fang Z; Huang J
    Front Genet; 2019; 10():906. PubMed ID: 31632439
    [No Abstract]   [Full Text] [Related]  

  • 2. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
    Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
    Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new prognostic model for glioblastoma multiforme based on coagulation-related genes.
    Zhou M; Deng Y; Fu Y; Liang R; Liu Y; Liao Q
    Transl Cancer Res; 2023 Oct; 12(10):2898-2910. PubMed ID: 37969372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a novel prognostic signature based on transcription factors in breast cancer by bioinformatics analysis.
    Yang Y; Li Z; Zhong Q; Zhao L; Wang Y; Chi H
    Gland Surg; 2022 May; 11(5):892-912. PubMed ID: 35694087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme.
    Sun R; Pan Y; Mu L; Ma Y; Shen H; Long Y
    Front Genet; 2021; 12():768930. PubMed ID: 34733320
    [No Abstract]   [Full Text] [Related]  

  • 7. Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma.
    Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
    Aging (Albany NY); 2019 Dec; 11(24):12246-12269. PubMed ID: 31844032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A risk signature with four autophagy-related genes for predicting survival of glioblastoma multiforme.
    Wang Y; Zhao W; Xiao Z; Guan G; Liu X; Zhuang M
    J Cell Mol Med; 2020 Apr; 24(7):3807-3821. PubMed ID: 32065482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction.
    Niu X; Sun J; Meng L; Fang T; Zhang T; Jiang J; Li H
    Front Oncol; 2020; 10():590352. PubMed ID: 33392085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetraspanins predict the prognosis and characterize the tumor immune microenvironment of glioblastoma.
    Li YC; Wu Y; Chen G; Zhu LZ; Luo X; Nie QQ; Zhang L; Zuo CJ
    Sci Rep; 2023 Aug; 13(1):13317. PubMed ID: 37587203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma.
    Yang Y; Ye X; Zhang H; Lin Z; Fang M; Wang J; Yu Y; Hua X; Huang H; Xu W; Liu L; Lin Z
    Front Genet; 2022; 13():1068837. PubMed ID: 36685838
    [No Abstract]   [Full Text] [Related]  

  • 12. Comprehensive analysis of genes based on chr1p/19q co-deletion reveals a robust 4-gene prognostic signature for lower grade glioma.
    Zhang C; Yu R; Li Z; Song H; Zang D; Deng M; Fan Y; Liu Y; Zhang Y; Qu X
    Cancer Manag Res; 2019; 11():4971-4984. PubMed ID: 31213913
    [No Abstract]   [Full Text] [Related]  

  • 13. An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients.
    Zhu G; Xia H; Tang Q; Bi F
    Cancer Cell Int; 2021 Mar; 21(1):166. PubMed ID: 33712026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Transcription Factor-Based Risk Model for Predicting the Prognosis of Prostate Cancer and Potential Therapeutic Drugs.
    Luo R; Huang M; Wang Y
    Evid Based Complement Alternat Med; 2021; 2021():6894278. PubMed ID: 34853602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme.
    Yang J; Wang L; Xu Z; Wu L; Liu B; Wang J; Tian D; Xiong X; Chen Q
    Front Genet; 2020; 11():253. PubMed ID: 32296458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
    Lei CG; Jia XY; Sun WJ
    Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
    Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
    J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Genomic Instability-Associated Prognostic Signature for Glioblastoma Patients.
    Chen X; Tian F; Wu Z
    World Neurosurg; 2022 Nov; 167():e515-e526. PubMed ID: 35977679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of Potential Glioblastoma Multiforme-Related miRNA-mRNA Regulatory Network.
    Lou W; Ding B; Xu L; Fan W
    Front Mol Neurosci; 2019; 12():66. PubMed ID: 30971889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.